The up-regulation of MRP1 expression underlies the multidrug resistance mechanisms in various tumours, including high-grade gliomas, as well as glioblastoma cell lines, such as T98G [18,54,55,56]. This evidence concerns the gene ABCC1 and central nervous system cancer.